Two Sigma Advisers »

Black Diamond Therapeutics shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $289k 103k 2.81
2023-09-30 $81k 28k 2.87
2023-06-30 $65k 13k 5.05
2023-03-31 $333k 176k 1.89
2022-12-31 $383k 213k 1.80
2022-09-30 $363k 215k 1.69
2022-06-30 $660k 268k 2.46
2022-03-31 $819k 296k 2.77
2021-12-31 $1.1M 199k 5.33
2021-09-30 $1.5M 181k 8.46
2021-06-30 $1.0M 84k 12.19
2021-03-31 $1.0M 43k 24.25
2020-12-31 $1.0M 32k 32.04